Constantiam Biosciences

About:

Constantiam Biosciences is the resource for functional evidence in clinical genetics.

Website: https://www.constantiambio.com/home

Top Investors: National Institute on Aging, National Human Genome Research Institute

Description:

Constantiam Biosciences is the resource for functional evidence in clinical genetics. By offering in-depth curation, rigorous analysis, and clear presentation of data from high-throughput genetic variant studies, MAVEvidence significantly boosts productivity and saves time for professionals in the field.

Total Funding Amount:

$2.54M

Headquarters Location:

Founded Date:

2020-01-01

Contact Email:

inquiries(AT)constantiambio.com.

Founders:

Daniel Goldman, Nicholas Schafer, Norman Kuok Ong

Number of Employees:

1-10

Last Funding Date:

2024-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai